Compare Orion Office REIT Inc (ONL) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Orion Office REIT Inc vs ResMed Inc. — how do they compare? Orion Office REIT Inc trades at $2.62 (market cap $151.74M), while ResMed Inc. trades at $194 (market cap $28.40B). The key difference: ResMed Inc. is far larger — about 187.2× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays the higher dividend (3%). Which is the better fit depends on your goals.
| ONL | RMD | |
|---|---|---|
Market Cap | $151.74M | $28.40B |
Sector | Real Estate | Health |
52-Week High | $3.04 | $293.73 |
52-Week Low | $1.93 | $182.82 |
Enterprise Value | $635.39M | $27.58B |
Dividend Yield | 3% | 1.23% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
